Does CLOBETASOL Cause Malignant neoplasm progression? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with CLOBETASOL (CLOBETASOL PROPIONATE). This represents 0.1% of all adverse event reports for CLOBETASOL.
6
Reports of Malignant neoplasm progression with CLOBETASOL
0.1%
of all CLOBETASOL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CLOBETASOL?
Of the 6 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBETASOL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBETASOL Cause?
Drug ineffective (3,217)
Psoriasis (1,317)
Product use in unapproved indication (706)
Pruritus (697)
Therapeutic product effect incomplete (643)
Skin exfoliation (550)
Off label use (540)
Treatment failure (535)
Erythema (464)
Arthralgia (417)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CLOBETASOL Alternatives Have Lower Malignant neoplasm progression Risk?
CLOBETASOL vs CLOBETASONE
CLOBETASOL vs CLODRONATE
CLOBETASOL vs CLOFARABINE
CLOBETASOL vs CLOFAZIMINE
CLOBETASOL vs CLOMETHIAZOLE